The Gross Margin of Samsung Biologics Co Ltd (207940.KS) is 50.38%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 50.38% |
2023-12-31 | 48.79% |
2022-12-31 | 48.93% |
2021-12-31 | 46.33% |
2020-12-31 | 35.72% |
2019-12-31 | 27.37% |
2018-12-31 | 27.09% |
2017-12-31 | 28.37% |
2016-12-31 | 9.01% |
2015-12-31 | -25.75% |